Using Microarray Analysis as a Prognostic and Predictive Tool in Oncology: Focus on Breast Cancer and Normal Tissue Toxicity

Seminars in Radiation Oncology

Volumn 18, Issue 2, 2008, Pages 105-114

  Nuyten, Dimitry S A ^a   van de Vijver, Marc J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; PACLITAXEL;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER STAGING; CANCER SURGERY; CELL DIFFERENTIATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; MASTECTOMY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE FIBER; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SUBCUTANEOUS TISSUE;

EID: 39749202894     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2007.10.007     Document Type: Article

References (50)

1. Brown P.O., and Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 21 (1999) 33-37
2. Schena M., Shalon D., Davis R.W., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
3. DeRisi J., Penland L., Brown P.O., et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14 (1996) 457-460
4. Eisen M.B., Spellman P.T., Brown P.O., et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 (1998) 14863-14868
5. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
6. Tibshirani R., Hastie T., Narasimhan B., et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99 (2002) 6567-6572
7. Bair E., and Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2 (2004) E108
8. Michiels S., Koscielny S., and Hill C. Prediction of cancer outcome with microarrays: A multiple random validation strategy. Lancet 365 (2005) 488-492
9. Hummerich J., Werle-Schneider G., Popanda O., et al. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy. Int J Radiat Biol 82 (2006) 593-604
10. Svensson J.P., Stalpers L.J., Esveldt-van Lange R.E., et al. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 3 (2006) e422
11. Vozenin-Brotons M.C., Milliat F., Linard C., et al. Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridization. Radiat Res 161 (2004) 299-311
12. Harima Y., Togashi A., Horikoshi K., et al. Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 60 (2004) 237-248
13. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
14. Kitahara O., Katagiri T., Tsunoda T., Harima Y., and Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 4 (2002) 295-303
15. Helland S., Johnsen H., Froyland C., et al. Radiation-induced effects on gene expression: An in vivo study on breast cancer. Radiother Oncol 80 (2006) 230-235
16. Overgaard M., Nielsen H.M., and Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports?. A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82 (2007) 247-253
17. Pierce L.J. The use of radiotherapy after mastectomy: A review of the literature. J Clin Oncol 23 (2005) 1706-1717
18. Cheng S.H., Horng C.F., West M., et al. Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol 24 (2006) 4594-4602
19. Kreike B., Halfwerk H., Kristel P., et al. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy. Clin Cancer Res 12 (2006) 5705-5712
20. Nuyten D.S., Kreike B., Hart A.A., et al. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8 (2006) R62
21. Chang H.Y., Sneddon J.B., Alizadeh A.A., et al. Gene expression signature of fibroblast serum response predicts human cancer progression: Similarities between tumors and wounds. PLoS Biol 2 (2004) E7
22. Chi J.T., Wang Z., Nuyten D.S., et al. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med 3 (2006) e47
23. Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
24. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16 (1998) 2672-2685
25. Sotiriou C., Powles T.J., Dowsett M., et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res 4 (2002) R3
26. Chang J., Wooten E., Tsimelzon A., et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362 (2003) 362-369
27. Hess K.R., Anderson K., Symmans W.F., et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24 (2006) 4236-4244
28. Hannemann J., Oosterkamp H.M., Bosch C.A., et al. Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 23 (2005) 3331-3342
29. Potti A., Dressman H.K., Bild A., et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med 12 (2006) 1294-1300
30. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
31. Buyse M., Loi S., van't V.L., et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98 (2006) 1183-1192
32. MINDACT. http://www.eortc.be/services/unit/mindact/MINDACT_websiteii.asp Accessed November 29, 2007
33. Adjuvant! Online. http://www.adjuvantonline.co Accessed
34. Sotiriou C., Wirapati P., Loi S., et al. Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98 (2006) 262-272
35. Wang Y., Klijn J.G., Zhang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365 (2005) 671-679
36. Foekens J.A., Atkins D., Zhang Y., et al. Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol 24 (2006) 1665-1671
37. Desmedt C., Piette F., Loi S., et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG Multicenter Independent Validation Series. Clin Cancer Res 13 (2007) 3207-3214
38. Desmedt C., and Sotiriou C. Proliferation: The most prominent predictor of clinical outcome in breast cancer. Cell Cycle 5 (2006) 2198-2202
39. Fan C., Oh D.S., Wessels L., et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355 (2006) 560-569
40. Paik S., Shak S., Tang G., et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351 (2004) 2817-2826
41. Hu Z., Fan C., Oh D.S., et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7 (2006) 96
42. Perou C.M., Sorlie T., Eisen M.B., et al. Molecular portraits of human breast tumours. Nature 406 (2000) 747-752
43. Sorlie T., Perou C.M., Tibshirani R., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98 (2001) 10869-10874
44. Sorlie T., Tibshirani R., Parker J., et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 100 (2003) 8418-8423
45. Chang H.Y., Nuyten D.S., Sneddon J.B., et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102 (2005) 3738-3743
46. Ma X.J., Wang Z., Ryan P.D., et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5 (2004) 607-616
47. Perou C.M., Jeffrey S.S., van de R.M., et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 96 (1999) 9212-9217
48. Dvorak H.F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986) 1650-1659
49. Brown J.M., and Wilson W.R. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4 (2004) 437-447
50. Adler A.S., Lin M., Horlings H., et al. Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet 38 (2006) 421-430